Free Trial

Sonoma Pharmaceuticals (SNOA) Short Interest Ratio & Short Volume

Sonoma Pharmaceuticals logo
$3.22 -0.04 (-1.08%)
As of 01:42 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Sonoma Pharmaceuticals Short Interest Data

Sonoma Pharmaceuticals (SNOA) has a short interest of 80,900 shares, representing 5.09% of the float (the number of shares available for trading by the public). This marks a 53.51% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 1.72 million shares to cover all short positions.

Current Short Interest
80,900 shares
Previous Short Interest
52,700 shares
Change Vs. Previous Month
+53.51%
Dollar Volume Sold Short
$307,420.00
Short Interest Ratio
0.0 Days to Cover
Last Record Date
April 30, 2025
Outstanding Shares
1,616,000 shares
Float Size
1,590,000 shares
Short Percent of Float
5.09%
Today's Trading Volume
11,448 shares
Average Trading Volume
1,723,142 shares
Today's Volume Vs. Average
1%
Short Selling Sonoma Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Sonoma Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SNOA Short Interest Over Time

SNOA Days to Cover Over Time

SNOA Percentage of Float Shorted Over Time

Sonoma Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202580,900 shares $307,420.00 +53.5%5.1%0 $3.80
4/15/202552,700 shares $137,020.00 -15.8%3.3%0 $2.60
3/31/202562,600 shares $137,094.00 -72.3%3.9%0 $2.19
3/15/2025225,900 shares $797,427.00 +2,205.1%14.2%0.2 $3.53
2/28/20259,800 shares $22,246.00 -36.8%0.6%0 $2.27
2/15/202515,500 shares $38,595.00 -62.7%1.0%0.1 $2.49
1/31/202541,500 shares $111,635.00 +75.1%2.6%0.1 $2.69
1/15/202523,700 shares $62,094.00 -36.1%1.8%0.1 $2.62
12/31/202437,100 shares $99,799.00 -45.2%2.8%0.1 $2.69
12/15/202467,700 shares $180,759.00 +67.6%5.1%0.2 $2.67
11/30/202440,400 shares $112,716.00 -47.5%3.1%0.1 $2.79
11/15/202477,000 shares $197,120.00 +40.8%5.8%0.2 $2.56
10/31/202454,700 shares $146,596.00 -31.5%4.1%0.3 $2.68
10/15/202479,900 shares $236,504.00 -25.0%6.1%0.5 $2.96
9/30/2024106,500 shares $326,955.00 +149.4%8.1%0.5 $3.07
9/15/202442,700 shares $149,450.00 -67.2%4.3%0.2 $3.50
8/31/2024130,300 shares $429,990.00 -65.4%13.0%0.7 $3.30
8/15/2024376,200 shares $88,369.38 -46.0%N/A0.1 $0.23
7/31/2024696,800 shares $254,332.00 +55.5%N/A0.1 $0.37
7/15/2024448,000 shares $174,540.80 -52.7%N/A0.1 $0.39
6/30/2024947,400 shares $201,038.28 +233.7%N/A0.2 $0.21
6/15/2024283,900 shares $50,761.32 -51.6%N/A0.1 $0.18
5/31/2024586,700 shares $120,097.49 +689.6%N/A0.3 $0.20
5/15/202474,300 shares $11,145.00 +59.1%N/A0.1 $0.15
4/30/202446,700 shares $7,420.63 -78.2%N/A0.1 $0.16
4/15/2024214,200 shares $34,571.88 +604.6%N/A0.2 $0.16
3/31/202430,400 shares $5,055.52 -74.2%N/A0 $0.17
3/15/2024117,800 shares $16,173.94 -3.1%N/A0.1 $0.14
2/29/2024121,500 shares $17,860.50 +21.3%N/A0.1 $0.15
2/15/2024100,200 shares $15,621.18 -21.2%N/A0 $0.16
1/31/2024127,200 shares $23,544.72 -81.2%N/A0.1 $0.19
1/15/2024675,100 shares $124,623.46 +238.2%N/A0.4 $0.18
12/31/2023199,600 shares $36,007.84 -48.3%N/A0.2 $0.18
12/15/2023386,000 shares $55,931.40 +348.3%N/A0.4 $0.14
11/30/202386,100 shares $15,222.48 +13.4%N/A0.1 $0.18
11/15/202375,900 shares $12,614.58 +56.2%N/A0.3 $0.17
10/31/202348,600 shares $7,946.10 +17.1%N/A0.3 $0.16
10/15/202341,500 shares $31,955.00 +15.9%N/A1.6 $0.77
9/30/202335,800 shares $27,634.02 -28.1%N/A1.6 $0.77
9/15/202349,800 shares $47,200.44 +16.6%N/A2.1 $0.95
Trump’s Bitcoin Reserve is No Accident… (Ad)

Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new blockchain development…

Just click here to get all the details on this crypto coin now
8/31/202342,700 shares $37,255.75 +42.3%N/A0.1 $0.87
8/15/202330,000 shares $27,600.00 -19.8%N/A0.1 $0.92
7/31/202337,400 shares $40,392.00 -29.6%N/A0.1 $1.08
7/15/202353,100 shares $61,065.00 -35.3%N/A0.1 $1.15
6/30/202382,100 shares $87,847.00 -71.5%N/A0.2 $1.07
6/15/2023287,700 shares $376,887.00 +251.7%N/A0.5 $1.31
5/31/202381,800 shares $78,528.00 +7.8%N/A0.1 $0.96
5/15/202375,900 shares $76,218.78 -40.1%N/A0.4 $1.00
4/30/2023126,600 shares $120,054.78 -24.2%N/A0.7 $0.95
4/15/2023167,100 shares $162,087.00 -25.1%N/A0.1 $0.97
3/31/2023223,100 shares $217,812.53 +50.6%N/A0.1 $0.98
3/15/2023148,100 shares $146,663.43 +58.6%N/A0.1 $0.99
2/28/202393,400 shares $113,948.00 -15.0%N/A0.1 $1.22
2/15/2023109,900 shares $168,147.00 -76.5%N/A0.1 $1.53
1/31/2023466,700 shares $774,722.00 +856.4%N/A0.3 $1.66
1/15/202348,800 shares $61,000.00 -4.7%N/A0 $1.25
12/30/202251,200 shares $57,344.00 -46.1%N/A0.1 $1.12
12/15/202295,000 shares $132,050.00 -1.0%N/A0.1 $1.39
11/30/202296,000 shares $164,160.00 -36.6%N/A0.1 $1.71
11/15/2022151,400 shares $337,622.00 +1,974.0%N/A0.2 $2.23
10/31/20227,300 shares $14,527.00 +942.9%N/A0 $1.99
10/15/2022700 shares $1,330.00 -22.2%N/A0 $1.90
9/30/2022900 shares $1,917.00 -84.8%N/A0 $2.13
9/15/20225,900 shares $17,641.00 -19.2%N/A0.1 $2.99
8/31/20227,300 shares $20,294.00 -47.1%N/A0.1 $2.78
8/15/202213,800 shares $45,057.00 -51.9%N/A0.2 $3.27
7/31/202228,700 shares $84,091.00 +36.0%N/A0.2 $2.93
7/15/202221,100 shares $61,190.00 -35.1%N/A0 $2.90
6/30/202232,500 shares $94,900.00 -11.0%N/A0 $2.92
6/15/202236,500 shares $109,500.00 +17.7%N/A0 $3.00
5/31/202231,000 shares $106,950.00 -83.3%N/A0 $3.45
5/15/2022185,500 shares $638,120.00 +138.4%N/A0.2 $3.44
4/30/202277,800 shares $206,948.00 -14.5%N/A0.1 $2.66
4/15/202291,000 shares $290,290.00 +85.0%N/A0.7 $3.19
3/31/202249,200 shares $197,292.00 -3.9%N/A0.3 $4.01
3/15/202251,200 shares $143,360.00 +36.5%N/A1.3 $2.80
2/28/202237,500 shares $119,250.00 -31.6%N/A0.8 $3.18
2/15/202254,800 shares $192,348.00 -34.1%N/A0.9 $3.51
1/31/202283,200 shares $315,328.00 -22.1%N/A0.5 $3.79
1/15/2022106,800 shares $491,280.00 +3.8%N/A0.5 $4.60
12/31/2021102,900 shares $469,224.00 -27.7%N/A0 $4.56
12/15/2021142,300 shares $668,810.00 -19.5%N/A0.1 $4.70
11/30/2021176,800 shares $937,040.00 -28.7%N/A0.1 $5.30
11/15/2021248,000 shares $1.39 million +11.9%N/A0.2 $5.60
10/29/2021221,700 shares $1.29 million -29.9%N/A0.1 $5.80
10/15/2021316,300 shares $1.98 million -61.3%N/A0.1 $6.27
9/30/2021816,800 shares $4.56 million +830.3%N/A0.3 $5.58
9/15/202187,800 shares $462,706.00 +18.7%N/A0 $5.27
8/31/202174,000 shares $469,160.00 -6.2%N/A0 $6.34
8/13/202178,900 shares $455,253.00 -43.3%N/A0 $5.77
Trump’s Bitcoin Reserve is No Accident… (Ad)

For the first time in history, we have a president who understands crypto's potential to bypass the banking system entirely. And Wall Street's biggest players know it. I've created a blueprint revealing how everyday investors can turn this historic shift into potentially life-changing wealth. Like the 75,000 new millionaires created in the last bull run— only this time with institutional backing.

Click Here to Check Out the Crypto Bull Run Millionaire Blueprint
7/30/2021139,200 shares $934,032.00 +110.3%N/A1.4 $6.71
7/15/202166,200 shares $421,694.00 +442.6%3.2%0.9 $6.37
6/30/202112,200 shares $89,548.00 +19.6%0.6%0.2 $7.34
6/15/202110,200 shares $80,376.00 -34.2%0.5%0 $7.88
5/28/202115,500 shares $118,420.00 -18.9%0.8%0.1 $7.64
5/14/202119,100 shares $135,992.00 -23.6%0.9%0.1 $7.12
4/30/202125,000 shares $192,500.00 -18.8%1.2%0.1 $7.70
4/15/202130,800 shares $255,948.00 +48.8%1.5%0.1 $8.31
3/31/202120,700 shares $141,795.00 +1,781.8%1.0%0.1 $6.85
3/15/20211,100 shares $8,096.00 -71.8%0.1%0 $7.36
2/26/20213,900 shares $32,409.00 -79.7%0.2%0 $8.31
2/12/202119,200 shares $170,880.00 -9.9%0.9%0 $8.90
1/29/202121,300 shares $189,357.00 -27.3%1.0%0 $8.89
1/15/202129,300 shares $237,330.00 -73.6%1.4%0 $8.10
12/31/2020111,000 shares $805,860.00 -80.9%5.4%0.1 $7.26
12/15/2020582,200 shares $4.84 million +14,828.2%28.3%0.6 $8.31
11/30/20203,900 shares $26,676.00 -44.3%0.2%0.1 $6.84
11/15/20207,000 shares $55,300.00 -17.7%0.4%0.1 $7.90
10/30/20208,500 shares $64,855.00 -48.8%0.4%0.1 $7.63
10/15/202016,600 shares $137,579.14 +8.5%0.8%0 $8.29
9/30/202015,300 shares $127,755.00 -26.1%0.8%0 $8.35
9/15/202020,700 shares $151,058.25 -39.3%1.0%0 $7.30
8/31/202034,100 shares $251,317.00 -7.1%1.7%0.1 $7.37
8/14/202036,700 shares $277,452.00 -93.1%1.8%0 $7.56
7/31/2020532,600 shares $4.89 million +3,089.2%27.5%0.5 $9.18
7/15/202016,700 shares $113,059.00 +9.9%0.9%0 $6.77
6/30/202015,200 shares $113,240.00 +223.4%0.9%0 $7.45
6/15/20204,700 shares $31,208.00 +30.6%0.3%0 $6.64
5/29/20203,600 shares $34,920.00 +414.3%0.2%0 $9.70

SNOA Short Interest - Frequently Asked Questions

What is Sonoma Pharmaceuticals' current short interest?

Short interest is the volume of Sonoma Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 80,900 shares of SNOA short. 5.09% of Sonoma Pharmaceuticals' shares are currently sold short. Learn More on Sonoma Pharmaceuticals' current short interest.

What is a good short interest percentage for Sonoma Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.09% of Sonoma Pharmaceuticals' floating shares are currently sold short.

Is Sonoma Pharmaceuticals' short interest increasing or decreasing?

Sonoma Pharmaceuticals saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 80,900 shares, an increase of 53.5% from the previous total of 52,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Sonoma Pharmaceuticals' float size?

Sonoma Pharmaceuticals currently has issued a total of 1,616,000 shares. Some of Sonoma Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Sonoma Pharmaceuticals currently has a public float of 1,590,000 shares.

How does Sonoma Pharmaceuticals' short interest compare to its competitors?

5.09% of Sonoma Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Sonoma Pharmaceuticals: Cognition Therapeutics, Inc. (1.82%), Q32 Bio Inc. (12.54%), Natural Alternatives International, Inc. (0.14%), X4 Pharmaceuticals, Inc. (7.59%), Lisata Therapeutics, Inc. (0.39%), Passage Bio, Inc. (3.42%), VYNE Therapeutics Inc. (1.57%), Lexaria Bioscience Corp. (3.26%), Chemomab Therapeutics Ltd. (0.74%), AlloVir, Inc. (2.56%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

What does it mean to sell short Sonoma Pharmaceuticals stock?

Short selling SNOA is an investing strategy that aims to generate trading profit from Sonoma Pharmaceuticals as its price is falling. SNOA shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Sonoma Pharmaceuticals?

A short squeeze for Sonoma Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SNOA, which in turn drives the price of the stock up even further.

How often is Sonoma Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNOA, twice per month. The most recent reporting period available is April, 30 2025.




This page (NASDAQ:SNOA) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners